Literature DB >> 30196327

2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes.

Lorenzo Gaetani1, Luca Prosperini2,3, Andrea Mancini1, Paolo Eusebi1, Maria Chiara Cerri1, Carlo Pozzilli2, Paolo Calabresi1,4, Paola Sarchielli1, Massimiliano Di Filippo5.   

Abstract

OBJECTIVES: To investigate the impact of the 2017 revisions of McDonald criteria on the diagnosis of multiple sclerosis (MS) in a cohort of patients with clinically isolated syndrome (CIS) and dissemination in space (DIS) of demyelinating lesions.
METHODS: We retrospectively analyzed 137 patients with CIS + DIS from two Italian MS centers.
RESULTS: Application of the 2017 revisions of McDonald criteria in our cohort led to a diagnosis of MS in 82.5% of the patients who could have not been diagnosed with MS according to the previous criteria at the time of the first demyelinating event. After a follow-up of 3.8 ± 2.9 years, 85.8% of these patients eventually satisfied also the previous (2010) criteria.
CONCLUSIONS: Application of the 2017 revisions of McDonald criteria results in an earlier diagnosis of MS in a large percentage of CIS patients destined to convert to MS.

Entities:  

Keywords:  Clinically isolated syndrome; Conversion; Diagnostic criteria; Dissemination in space; Dissemination in time; Multiple sclerosis; Oligoclonal bands; Symptomatic gadolinium enhancing lesion

Mesh:

Substances:

Year:  2018        PMID: 30196327     DOI: 10.1007/s00415-018-9048-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

Review 1.  Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.

Authors:  Hans Link; Yu-Min Huang
Journal:  J Neuroimmunol       Date:  2006-09-01       Impact factor: 3.478

2.  Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.

Authors:  Massimo Filippi; Paolo Preziosa; Alessandro Meani; Olga Ciccarelli; Sarlota Mesaros; Alex Rovira; Jette Frederiksen; Christian Enzinger; Frederik Barkhof; Claudio Gasperini; Wallace Brownlee; Jelena Drulovic; Xavier Montalban; Stig P Cramer; Alexander Pichler; Marloes Hagens; Serena Ruggieri; Vittorio Martinelli; Katherine Miszkiel; Mar Tintorè; Giancarlo Comi; Iris Dekker; Bernard Uitdehaag; Irena Dujmovic-Basuroski; Maria A Rocca
Journal:  Lancet Neurol       Date:  2017-12-21       Impact factor: 44.182

Review 3.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Authors:  Alan J Thompson; Brenda L Banwell; Frederik Barkhof; William M Carroll; Timothy Coetzee; Giancarlo Comi; Jorge Correale; Franz Fazekas; Massimo Filippi; Mark S Freedman; Kazuo Fujihara; Steven L Galetta; Hans Peter Hartung; Ludwig Kappos; Fred D Lublin; Ruth Ann Marrie; Aaron E Miller; David H Miller; Xavier Montalban; Ellen M Mowry; Per Soelberg Sorensen; Mar Tintoré; Anthony L Traboulsee; Maria Trojano; Bernard M J Uitdehaag; Sandra Vukusic; Emmanuelle Waubant; Brian G Weinshenker; Stephen C Reingold; Jeffrey A Cohen
Journal:  Lancet Neurol       Date:  2017-12-21       Impact factor: 44.182

4.  Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

Authors:  J Kuhle; G Disanto; R Dobson; R Adiutori; L Bianchi; J Topping; J P Bestwick; U-C Meier; M Marta; G Dalla Costa; T Runia; E Evdoshenko; N Lazareva; E Thouvenot; P Iaffaldano; V Direnzo; M Khademi; F Piehl; M Comabella; M Sombekke; J Killestein; H Hegen; S Rauch; S D'Alfonso; J C Alvarez-Cermeño; P Kleinová; D Horáková; R Roesler; F Lauda; S Llufriu; T Avsar; U Uygunoglu; A Altintas; S Saip; T Menge; C Rajda; R Bergamaschi; N Moll; M Khalil; R Marignier; I Dujmovic; H Larsson; C Malmestrom; E Scarpini; C Fenoglio; S Wergeland; A Laroni; V Annibali; S Romano; A D Martínez; A Carra; M Salvetti; A Uccelli; Ø Torkildsen; K M Myhr; D Galimberti; K Rejdak; J Lycke; J L Frederiksen; J Drulovic; C Confavreux; D Brassat; C Enzinger; S Fuchs; I Bosca; J Pelletier; C Picard; E Colombo; D Franciotta; T Derfuss; Rlp Lindberg; Ö Yaldizli; L Vécsei; B C Kieseier; H P Hartung; P Villoslada; A Siva; A Saiz; H Tumani; E Havrdová; L M Villar; M Leone; N Barizzone; F Deisenhammer; C Teunissen; X Montalban; M Tintoré; T Olsson; M Trojano; S Lehmann; G Castelnovo; S Lapin; R Hintzen; L Kappos; R Furlan; V Martinelli; G Comi; S V Ramagopalan; G Giovannoni
Journal:  Mult Scler       Date:  2015-02-13       Impact factor: 6.312

5.  Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis.

Authors:  Luanne M Metz; Misha Eliasziw
Journal:  N Engl J Med       Date:  2017-08-24       Impact factor: 91.245

6.  New versus old: Implications of evolving diagnostic criteria for relapsing-remitting multiple sclerosis.

Authors:  Nuala McNicholas; Andrew Lockhart; Siew M Yap; Karen O'Connell; Niall Tubridy; Michael Hutchinson; Christopher McGuigan
Journal:  Mult Scler       Date:  2018-04-12       Impact factor: 6.312

Review 7.  Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients.

Authors:  Massimo Filippi; Maria A Rocca; Stefano Bastianello; Giancarlo Comi; Paolo Gallo; Massimo Gallucci; Angelo Ghezzi; Maria Giovanna Marrosu; Giorgio Minonzio; Patrizia Pantano; Carlo Pozzilli; Gioacchino Tedeschi; Maria Trojano; Andrea Falini; Nicola De Stefano
Journal:  Neurol Sci       Date:  2013-07-05       Impact factor: 3.307

8.  A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.

Authors:  Alex Rovira; Josephine Swanton; Mar Tintoré; Elena Huerga; Fredrick Barkhof; Massimo Filippi; Jette L Frederiksen; Annika Langkilde; Katherine Miszkiel; Chris Polman; Marco Rovaris; Jaume Sastre-Garriga; David Miller; Xavier Montalban
Journal:  Arch Neurol       Date:  2009-05

9.  Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis.

Authors:  Rebecca Beesley; Valerie Anderson; Katharine E Harding; Fady Joseph; Valentina Tomassini; Trevor P Pickersgill; Neil P Robertson; Emma C Tallantyre
Journal:  Mult Scler       Date:  2018-05-15       Impact factor: 6.312

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  6 in total

Review 1.  Apparent changes in the epidemiology and severity of multiple sclerosis.

Authors:  Nils Koch-Henriksen; Melinda Magyari
Journal:  Nat Rev Neurol       Date:  2021-09-28       Impact factor: 42.937

Review 2.  Re-Evaluating the Use of IFN-β and Relapsing Multiple Sclerosis: Safety, Efficacy and Place in Therapy.

Authors:  Carolyn H Goldschmidt; Le H Hua
Journal:  Degener Neurol Neuromuscul Dis       Date:  2020-06-26

3.  "Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.

Authors:  Massimiliano Calabrese; Claudio Gasperini; Carla Tortorella; Gianmarco Schiavi; Giovanni Frisullo; Paolo Ragonese; Roberta Fantozzi; Luca Prosperini; Pietro Annovazzi; Cinzia Cordioli; Massimiliano Di Filippo; Diana Ferraro; Alberto Gajofatto; Simona Malucchi; Salvatore Lo Fermo; Giovanna De Luca; Maria L Stromillo; Eleonora Cocco; Antonio Gallo; Damiano Paolicelli; Roberta Lanzillo; Valentina Tomassini; Ilaria Pesci; Maria E Rodegher; Claudio Solaro
Journal:  Neurology       Date:  2019-05-01       Impact factor: 9.910

4.  CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis.

Authors:  Michael Mazzucco; William Mannheim; Samantha V Shetty; Jennifer R Linden
Journal:  Fluids Barriers CNS       Date:  2022-02-08

5.  Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States.

Authors:  Andrew J Solomon; Marwa Kaisey; Stephen C Krieger; Salim Chahin; Robert T Naismith; Sarah M Weinstein; Russell T Shinohara; Brian G Weinshenker
Journal:  Mult Scler       Date:  2021-10-06       Impact factor: 5.855

6.  IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis.

Authors:  Yang Zheng; Meng-Ting Cai; Fan Yang; Ji-Ping Zhou; Wei Fang; Chun-Hong Shen; Yin-Xi Zhang; Mei-Ping Ding
Journal:  Front Immunol       Date:  2020-08-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.